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ABSTRACT
Secondary metabolites produced by bacteria and
fungi are an important source of antimicro-
bials and other bioactive compounds. In recent
years, genome mining has seen broad applica-
tions in identifying and characterizing new com-
pounds as well as in metabolic engineering.
Since 2011, the ‘antibiotics and secondary metabo-
lite analysis shell––antiSMASH’ (https://antismash.
secondarymetabolites.org) has assisted researchers
in this, both as a web server and a standalone tool.
It has established itself as the most widely used
tool for identifying and analysing biosynthetic gene
clusters (BGCs) in bacterial and fungal genome se-
quences. Here, we present an entirely redesigned
and extended version 5 of antiSMASH. antiSMASH
5 adds detection rules for clusters encoding the
biosynthesis of acyl-amino acids, -lactones, fungal
RiPPs, RaS-RiPPs, polybrominated diphenyl ethers,
C-nucleosides, PPY-like ketones and lipolanthines.
For type II polyketide synthase-encoding gene clus-
ters, antiSMASH 5 now offers more detailed predic-
tions. The HTML output visualization has been re-
designed to improve the navigation and visual repre-
sentation of annotations. We have again improved
the runtime of analysis steps, making it possible
to deliver comprehensive annotations for bacterial
genomes within a few minutes. A new output file in
the standard JavaScript object notation (JSON) for-
mat is aimed at downstream tools that process anti-
SMASH results programmatically.
INTRODUCTION
Bacterial and fungal natural products constitute a key
source of scaffolds for the development of antimicrobials
and other drugs (1), and mediate ecological interactions be-
tween organisms in various ways (2).
Mining genomic data for the presence of biosynthetic
pathways that enable organisms to produce such molecules,
which are also referred to as secondary or specialized
metabolites, have become an essential approach that com-
plements activity- and chemistry-guided isolation and iden-
tification approaches (3). Several computational tools, such
as CLUSEAN (4) or PRISM (5), have been developed to
support scientists with this task. The ‘antibiotics and sec-
ondary metabolites analysis shell’, antiSMASH, is a pio-
neer amongst these tools. Initially released in 2011 (6), it
has since been further extended and improved (7–12), and
is currently used by thousands of academic and industrial
scientists worldwide to identify so called secondarymetabo-
lite ‘biosynthetic gene clusters’ (BGCs) in their genomes of
interest. In 2017, a database component was added to the
antiSMASH framework, which provides instant access to
thousands of pre-computed antiSMASH genome mining
results of publicly available genomes (13,14). Furthermore,
several independent tools, such as the mass-spectrometry
guided peptide mining tool Pep2Path (15), the ‘Antibiotic
Resistance Target Seeker’ ARTS (16), the sgRNA design
tool CRISPy-web (17), a reverse-tailoring tool to match fin-
ishedNRPS/PKS structures to antiSMASH-predicted core
structures (18) and the BGC clustering and classification
platform BiG-SCAPE (19) were developed that directly in-
teract with and interpret results generated by antiSMASH
and provide information that is outside the scope of a core-
antiSMASH analysis.
Here, we present version 5 of antiSMASH, which con-
tains many improvements. In addition to many features
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visible to the end users, such as extended and improved
BGC detection and analysis capabilities and a mod-
ernized and improved User Interface (see below), anti-
SMASH version 5 was completely rewritten in Python
version 3 and the code was restructured to increase
performance, reliability and ease of maintenance. This
has led to a significant speed increase of the pipeline.
A complete list of antiSMASH 5 features is included
in the antiSMASH documentation https://docs.antismash.
secondarymetabolites.org/antiSMASH5features/.
NEW FEATURES AND UPDATES
New gene cluster classes and refinement of cluster detection
rules
The most widely used and recommended mode to detect
BGCs in genomic data is via manually curated and val-
idated gene cluster rules. These are based on identifying
co-occurring conserved core enzymes in the genome using
HMM-profiles that were derived from Pfam (20), SMART
(21), BAGEL (22) or Yadav et al. (23), or that were cre-
ated specifically for antiSMASH. While antiSMASH ver-
sion 4 supported the rule-based detection of 44 differ-
ent biosynthetic types, antiSMASH 5 now includes rules
for 52 different BGC types. In version 5, new rules were
added to detect BGCs encoding the biosynthesis of N-acyl
amino acids (24), -lactones (25), polybrominated diphenyl
ethers (26), C-nucleosides (27), pseudopyronines (28), fun-
gal RiPPs (29–31) and RaS-RiPPs (32,33). Furthermore, a
new ‘nrps-like’ rule was defined for NRPS-fragments, i.e.
atypical NRPSs that don’t have the typical C-A-T module
architecture. The previous ‘otherks’ rule was split into two
rules to individually assign heterocyst glycolipid synthase-
like clusters and other atypical PKSs. In addition, some
rules were improved based on user case reports. The rules
describing lanthipeptides and trans-AT type I PKS were re-
fined to reduce the number of false positive hybrid calls on
other cluster types. For trans-AT- type I PKS and type II
PKS, we increased the size of the cluster cutoffs to capture
previously missed tailoring enzymes in published clusters.
The rule for linear azole/azoline-containing peptides was
made more generic to better cover the range of described
clusters.
The rule describingmicrocin clusters was removed, asmi-
crocins are a class of RiPPs defined via their production
in Enterobacteriaceae, and are already captured by one of
our other specific RiPP cluster rules, depending on their re-
spective biosynthesis pathway (e.g. microcin J25-like RiPPs
were previously covered by the oldmicrocin cluster rules but
chemically are lasso peptides, while microcin B17 is a linear
azol(in)e-containing peptide).
Improved type II PKS prediction
Bacterial type II PKS BGCs code for the biosynthesis of
aromatic polyketides, such as the antibiotic tetracycline or
the anti-tumour drug doxorubicin. From the beginning, an-
tiSMASH has had rules that were able to detect type II
PKS BGCs by checking for the presence of the KSα and
KSβ/CLF component of the minimal PKS. However, no
detailed prediction methods had been added since anti-
SMASH’s first version. In antiSMASH 5, we introduce a
new PKS II analysis module (12), which uses a collection of
manually curated HMMs to predict potential starter units,
the number of elongation cycles (and thus a rough esti-
mation of the putative molecular weight of the core com-
pound), cyclization patterns and some conserved type II
PKS specific tailoring reactions. This module is automat-
ically triggered whenever a type II PKS BGC is detected.
Annotation of resistance genes via Resfams
The Resfams database (34) is a curated database of protein
families with confirmed antibiotic resistance function. an-
tiSMASH 5 uses the profile Hidden Markov Models (pH-
MMs) from Resfams to annotate potential resistance genes
found in predicted gene regions. Potential resistance gene-
hits are displayed in the ‘gene details’ panel alongwith other
functional annotations.
GO-term annotations
The Gene Ontology (GO) is a controlled vocabulary for de-
scribing biological processes, molecular functions and cel-
lular components in a consistent way to enable comparison
of these between different species. Amongst its wide range
of uses, the GO has been used to predict gene clusters in
eukaryotes and bacteria (35) and, in conjunction with anti-
SMASH, to refine cluster boundaries in antiSMASH out-
put for Aspergillus species (36).
To facilitate these and other GO-based analyses, anti-
SMASH 5 includes an option to automatically annotate
GO terms on Pfam domains. This functionality makes use
of the fact that GO terms may be linked not only to spe-
cific gene products, but also to other means of classifica-
tion in so-called ‘mappings’ (http://geneontology.org/page/
download-mappings). As antiSMASH can automatically
annotate Pfam domains, the GO annotation functionality
makes use of the Pfam to GO mapping supplied by the
Gene Ontology Consortium’s website (37). If the ID of a
predicted Pfam domain in an antiSMASH record is present
in the Pfam to GO mapping, the respective GO terms are
assigned and presented in the ‘gene details’ panel.
Link to the antiSMASH database
antiSMASH provides options to search for similar gene
clusters in public datasets. As already implemented in previ-
ous versions of the software, the KnownClusterBlast func-
tionality searches each identified region against the man-
ually curated MIBiG (38) repository. The KnownClus-
terBlast and ClusterBlast search functions use an algo-
rithm first described in antiSMASH 1 (6), which also is
in use in a generalized version in MultiGeneBlast (39).
In the previous versions of antiSMASH, the ClusterBlast
databasewas generated by scripts that used the antiSMASH
BGC detection logic on sequences downloaded from the
NCBI Genbank/RefSeq databases. As version 2 of the
antiSMASH database now also contains BGCs of draft
genomes (14), starting with antiSMASH 5 the ClusterBlast
databases will be directly generated from the new anti-
SMASH database and complemented with individual BGC
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records that were submitted to NCBI outside of whole-
genome submissions. This provides several advantages: The
abundance of entries for selected genera/species in the pub-
lic databases (and thus also in the previous ClusterBlast
database) is strongly skewed towards clinically or industri-
ally relevant organisms. There are, for example, more than
15 000 assemblies for Escherichia coli deposited at NCBI.
For the antiSMASH database, a sequence-based dereplica-
tion workflow was established (14) that reduced the num-
ber of redundant entries with very high sequence similarity.
Thus, the updated ClusterBlast database contains fewer en-
tries than the previous release, despite the increase in pub-
licly available sequence data. This decrease has resulted in
reduced computation times, while simultaneously providing
more relevant hits. Furthermore, as the entries of the Clus-
terBlast database are directly related to the BGCs in the an-
tiSMASH database, a link to the respective BGC is now in-
cluded for all ClusterBlast hits, promptly directing the user
to the detailed report of the similar gene clusters.
New ‘region’ concept
In previous versions, antiSMASH referred to all co-located,
hybrid and independent BGCswith the single label ‘cluster’.
In many cases, this led to confusing structure predictions
when distinct BGCs are encoded side-by-side. For example,
many Streptomyces plasmids exist for which all BGCs lie so
close to each other that all were joined into a single large
‘cluster’. In order to better distinguish the different biolog-
ical options that lead to BGCs, antiSMASH 5 introduces
some new terminology.
The definitions now used in antiSMASH 5 are:
Core: The minimum area containing one or more genes
that code for enzymes for a single BGC type that are de-
tected by the manually curated detection rules. These genes
do not have to be contiguous, but can be within a certain
cutoff distance as defined by the detection rule for the BGC
type in question.
Neighbourhood: Distance up- and downstream of the
cluster core that is used to find tailoring genes/enzymes;
the neighbourhood distances for the individual biosynthetic
types were empirically determined and defined in the detec-
tion rules.
Protocluster: Contains core + neighbourhoods at both
sides of the core; each protocluster always will have one sin-
gle product type (for example, NRPS). Protoclusters may
overlap partially or completely with other protoclusters. In
the result webpage, protoclusters are displayed as boxes
above the gene arrows. The cores are shown as solid colour
boxes, the neighbourhoods are the half-transparent areas
around the cores.
Candidate cluster: Contains one or more protoclusters;
the candidate clusters are defined as described below. These
definitions better allow modelling of hybrid clusters, such
as PKS/NRPS hybrids, which combine two or more differ-
ent biosynthetic classes (as identified in the detection rules),
or cases where one class is used to biosynthesize a precur-
sor for a second class. An example of the latter is found in
glycopeptide biosynthesis, where one of the amino acids is
synthesized by a type III PKS, which is then incorporated
into the product by aNRPS.Candidate clustersmay overlap
partially or completely with other candidate clusters. In the
result webpage, candidate clusters are shown as boxes above
the protoclusters.
Region: Contains one or more candidate clusters; The re-
gions in antiSMASH 5 correspond to the entities called
‘clusters’ in antiSMASH 1 – 4 and now constitute what is
displayed on a page of the results webpage. Sometimes, a re-
gion will containmultiple mutually exclusive candidate clus-
ters; in such cases, comparative genomic analysis and/or ex-
perimental work is required to assess which of these candi-
date clusters constitute actual BGCs. Regions will not over-
lap with each other. At least one of the contained candidate
clusters will cover the full length of the region.
There are four kinds of candidate clusters: chemical hy-
brids, interleaved, neighbouring and single.
Chemical hybrid candidate clusters contain at least two
protoclusters that share at least one gene that codes for en-
zymes of two ormore separate BGC types (e.g. a single gene
coding for type I PKS andNRPSmodules) (Figure 1A). An
example of this type are hybrid PKS/NRPSs. Please note
that this type of candidate cluster can also include protoclus-
ters within that shared range that do not share a coding se-
quence provided that they are completely contained within
the candidate cluster.
Interleaved candidate clusters contain protoclusters that
do not share cluster-type-defining coding sequences, but
their core locations overlap (Figure 1B).
Neighbouring candidate clusters contain protoclusters
which transitively overlap in their neighbourhoods (Figure
1C).
Single candidate clusters (Figure 1D) exist for consistency
of access, they contain only a single protocluster. Note that
individual protoclusters can be contained by more than one
candidate cluster (typically a neighbouring candidate cluster
and one of single, interleaved or chemical hybrid).
Each candidate cluster assignment is transitive, for ex-
ample if a protocluster would form a chemical hybrid with
each of two neighbouring protoclusters, but these neigh-
bours would not form a chemical hybrid on their own, all
three together will still form a chemical hybrid candidate
cluster.
Improved user interface
A central aim of antiSMASH is to provide very detailed
and specific information via an easy to use and under-
stand user interface (UI). The UI remained principally un-
changed from the initial release of antiSMASH in 2011, de-
spite the increased functionality added with each new ver-
sion. In this version, we have modernized the UI using up-
dated web technologies that allow a better structuring of
the result-content of the antiSMASH results pages. For re-
designing the UI, it was important that the reliable and
well-established look-and-feel was conserved, while also re-
taining the ability to download the whole web-based results
folder and to display it locally in a variety of web-browsers.
We and others (such as (40)) have realized that anti-
SMASH results using the heuristic ClusterFinder algorithm
(41) were, more often than not, wrongly interpreted. At the
same time, ClusterFinder contributed significantly to the
computational workload. For these reasons, we decided to
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Figure 1. Candidate cluster types. 1,2,3,4: Grey/yellow: gene involved in protocluster A/B. (A) Chemical Hybrids. Since cluster type A and cluster type
B share a CDS that defines those protoclusters, they are classified as ‘chemical hybrid’. (B) Interleaved: Since none of the protoclusters share any defining
CDS with any other protocluster, it is not annotated as a chemical hybrid, even though the biosynthetic product may or may not be. The two protoclusters
form an interleaved candidate clusters, since the core of A overlaps with the core of B. (C) Neighbouring: Neighbouring candidate clusters are defined if the
neighbourhoods of two protoclusters but not their cores overlap. (D) Singles: If protoclusters don’t have any overlap/relation with other protoclusters, the
term single candidate cluster is assigned.
remove this feature from the pubic antiSMASH web server.
It is, of course, still included in the download version of an-
tiSMASH and can be enabled via the command line.
In the Regions overview section (Figure 2), a graph-
ical overview showing the location of the identified re-
gions on the chromosome/plasmid/scaffolds/contig is dis-
played. In the detailed view, regions that are located on
contig-borders are now clearly labelled. This often indi-
cates that parts of the BGC are missing or that several sec-
tions of a BGC are located on different contigs and are
therefore reported individually (for a more detailed discus-
sion on this phenomenon, please see (42)). For the first
time, antiSMASH 5 now offers interactive browsing of the
BGCs, including selection of ‘functional’ units, i.e. core en-
zymes, transporters, etc., zooming to individual genes or
regions/candidate clusters/protoclusters. Details of the se-
lection are now provided in side panels instead of pop-up
windows, using a hierarchical view of the analysis sum-
maries (which can be expanded by clicking ‘+’) to provide
additional details. For the display of the PKS/NRPS do-
main organization, the user now can choose whether to
limit the shown domains to the currently selected genes or
just display the results of the selected gene(s)/enzyme(s).
Furthermore, the information is now organized in ‘tabs’
that do not require scrolling down along an often very long
results page.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/47/W
1/W
81/5481154 by D
TU
 Library - Technical Inform
ation C
enter of D
enm
ark user on 18 July 2019
Nucleic Acids Research, 2019, Vol. 47, Web Server issue W85
Figure 2. Screenshot of the antiSMASH 5 user interface (example: NCBI-acc: Y16952; balhimycin BGC). The new region overview now allows
panning/zooming. The candidate cluster and protocluster boxes are explained in the ‘new region concept’ section above. Information about the currently
selected gene are displayed at the right ‘Gene details’ panel. For PKS or NRPS regions, the detailed domain annotation is displayed; by pressing the tabs,
users can select the domain overview (shown) or the ClusterBlast, KnownClusterBlast or SubClusterBlast results. At the right, the structure prediction
and details of specificity predictions are displayed upon selecting the plus sign.
CODE REFACTORING AND SPEED-UP
Large parts of the pre-antiSMASH 5 code base were still
derived from antiSMASH version 1, which was released in
2011. In order to maintain future compatibility, the anti-
SMASH code base had to be migrated from python 2.7,
which will reach end-of-life in 2020, to the current versions
3.5–3.7. As this transition required significant modification
to the antiSMASH code, we decided to take this as a chance
to completely rewrite the software with a special considera-
tion on runtime, code stability and code maintainability. A
unit test and integration test framework was implemented
that covers most parts of the antiSMASH 5 code allowing a
much easier debugging and––most importantly––extension
of the code while at the same time ensuring that new fea-
tures do not negatively impact the results of existing mod-
ules. For some of the externally contributedmodules (Sand-
puma, trans-ATPKS comparisons, terpene PrediCAT), our
contributors are currently preparing updated and compli-
ant versions, which will be added to antiSMASH 5 in mi-
nor releases once they are finished and tested. Like the ear-
lier antiSMASH versions, antiSMASH 5 provides the anal-
ysis results in an interactive webpage and richly annotated
GenBank-format files for the whole genome and individual
clusters. As a new feature in version 5, all data are also avail-
able as a computer readable JSON container, which allows
third party tools to easily process antiSMASH annotations.
This JSON output has superseded some other output types,
such as BioSynML and XLS.
In addition to the advantages mentioned above, the code
refactoring and cleanup has also led to a significant speed
increase of the new version by a factor of 4-11× (depending
on genome and selected options); instead of waiting times
of several hours, antiSMASH results are now usually deliv-
ered within 30–40 min after the start of the job for a typical
submission at the public web server.
CONCLUSIONS AND FUTURE PERSPECTIVES
With the help of software like antiSMASH, genomemining
for specialized metabolites has established itself as a com-
plementary approach for the identification of novel metabo-
lites, which is routinely used within the natural products re-
search community and increasingly applied in related fields
such as metagenomics, environmental biology or metabolic
engineering. With the improvements to the antiSMASH
user interface and performance, we keep pace with these de-
velopments. Furthermore, the complete refactoring of the
antiSMASH 5 code base will allow us to increasingly use
antiSMASH as a tool that provides analysis data on which
other software can perform additional analyses.
DATA AVAILABILITY
antiSMASH is available from https://antismash.
secondarymetabolites.org/ (bacterial version) or
https://fungismash.secondarymetabolites.org/ (fun-
gal version). The antiSMASH documentation,
including a PDF user guide, is available from
https://docs.antismash.secondarymetabolites.org. These
websites are free and open to all users and there is no login
requirement. The antiSMASH source code is available from
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https://github.com/antismash/antismash. antiSMASH is
also available via Docker.
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